Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1145

1.

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M.

Arch Gen Psychiatry. 2004 Nov;61(11):1136-44.

PMID:
15520361
[PubMed - indexed for MEDLINE]
2.

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW.

Arch Gen Psychiatry. 2006 Mar;63(3):298-304.

PMID:
16520435
[PubMed - indexed for MEDLINE]
3.

Effects of D-cycloserine on extinction: translation from preclinical to clinical work.

Davis M, Ressler K, Rothbaum BO, Richardson R.

Biol Psychiatry. 2006 Aug 15;60(4):369-75. Review.

PMID:
16919524
[PubMed - indexed for MEDLINE]
4.

A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.

Norberg MM, Krystal JH, Tolin DF.

Biol Psychiatry. 2008 Jun 15;63(12):1118-26. doi: 10.1016/j.biopsych.2008.01.012. Epub 2008 Mar 7.

PMID:
18313643
[PubMed - indexed for MEDLINE]
5.

A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.

Guastella AJ, Dadds MR, Lovibond PF, Mitchell P, Richardson R.

J Psychiatr Res. 2007 Sep;41(6):466-71. Epub 2006 Jul 10.

PMID:
16828803
[PubMed - indexed for MEDLINE]
6.

A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects.

Watson BJ, Wilson S, Griffin L, Kalk NJ, Taylor LG, Munafò MR, Lingford-Hughes AR, Nutt DJ.

Psychopharmacology (Berl). 2011 Jul;216(1):121-9. doi: 10.1007/s00213-011-2199-2. Epub 2011 Feb 12.

PMID:
21318564
[PubMed - indexed for MEDLINE]
7.

A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.

Guastella AJ, Richardson R, Lovibond PF, Rapee RM, Gaston JE, Mitchell P, Dadds MR.

Biol Psychiatry. 2008 Mar 15;63(6):544-9. doi: 10.1016/j.biopsych.2007.11.011. Epub 2008 Jan 7.

PMID:
18179785
[PubMed - indexed for MEDLINE]
8.

D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.

Kushner MG, Kim SW, Donahue C, Thuras P, Adson D, Kotlyar M, McCabe J, Peterson J, Foa EB.

Biol Psychiatry. 2007 Oct 15;62(8):835-8. Epub 2007 Jun 22.

PMID:
17588545
[PubMed - indexed for MEDLINE]
9.

Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.

Meyerbroeker K, Powers MB, van Stegeren A, Emmelkamp PM.

Psychother Psychosom. 2012;81(1):29-37. doi: 10.1159/000329454. Epub 2011 Nov 22.

PMID:
22116378
[PubMed - indexed for MEDLINE]
10.

Augmenting in vivo exposure with fear antagonistic actions: a preliminary test.

Wolitzky KB, Telch MJ.

Behav Ther. 2009 Mar;40(1):57-71. doi: 10.1016/j.beth.2007.12.006. Epub 2008 Jul 2.

PMID:
19187817
[PubMed - indexed for MEDLINE]
11.

D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.

Smits JA, Rosenfield D, Otto MW, Powers MB, Hofmann SG, Telch MJ, Pollack MH, Tart CD.

Biol Psychiatry. 2013 Jun 1;73(11):1054-8. doi: 10.1016/j.biopsych.2012.12.009. Epub 2013 Jan 16.

PMID:
23332511
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.

Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH, Yang MC, Jacob ML, Larson M, Hirsh A, Fernandez M, Geffken GR, Goodman WK.

Int Clin Psychopharmacol. 2007 Jul;22(4):230-7. Erratum in: Int Clin Psychopharmacol. 2007 Sep;22(5):312.

PMID:
17519647
[PubMed - indexed for MEDLINE]
13.

[Pharmacological support of exposure therapy in anxiety disorders. Animal experiment studies].

Koch M.

Nervenarzt. 2002 May;73(5):481-3. German.

PMID:
12078031
[PubMed - indexed for MEDLINE]
14.

Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.

Choi DC, Rothbaum BO, Gerardi M, Ressler KJ.

Curr Top Behav Neurosci. 2010;2:279-99. Review.

PMID:
21309114
[PubMed - indexed for MEDLINE]
15.

The development of virtual reality therapy (VRT) system for the treatment of acrophobia and therapeutic case.

Jang DP, Ku JH, Choi YH, Wiederhold BK, Nam SW, Kim IY, Kim SI.

IEEE Trans Inf Technol Biomed. 2002 Sep;6(3):213-7.

PMID:
12381037
[PubMed - indexed for MEDLINE]
16.

Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.

Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, Hofmann SG, Eisenmenger K, Krystal JH, Pollack MH.

Biol Psychiatry. 2010 Feb 15;67(4):365-70. doi: 10.1016/j.biopsych.2009.07.036. Epub 2009 Oct 6.

PMID:
19811776
[PubMed - indexed for MEDLINE]
17.

An fMRI study examining effects of acute D-cycloserine during symptom provocation in spider phobia.

Aupperle RL, Hale LR, Chambers RJ, Cain SE, Barth FX, Sharp SC, Denney DR, Savage CR.

CNS Spectr. 2009 Oct;14(10):556-71.

PMID:
20095368
[PubMed - indexed for MEDLINE]
18.

Effectiveness of computer-generated (virtual reality) graded exposure in the treatment of acrophobia.

Rothbaum BO, Hodges LF, Kooper R, Opdyke D, Williford JS, North M.

Am J Psychiatry. 1995 Apr;152(4):626-8.

PMID:
7694917
[PubMed - indexed for MEDLINE]
19.

The treatment of fear of flying: a controlled study of imaginal and virtual reality graded exposure therapy.

Wiederhold BK, Jang DP, Gevirtz RG, Kim SI, Kim IY, Wiederhold MD.

IEEE Trans Inf Technol Biomed. 2002 Sep;6(3):218-23.

PMID:
12381038
[PubMed - indexed for MEDLINE]
20.

Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.

Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE, Cannistraro P, Jenike MA, Rauch SL.

Am J Psychiatry. 2008 Mar;165(3):335-41; quiz 409. doi: 10.1176/appi.ajp.2007.07050776. Epub 2008 Feb 1.

PMID:
18245177
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk